Coronary vasodilatory action after nicorandil: a quantitative angiographic study

The American Journal of Cardiology
H Suryapranata, P W Serruys

Abstract

Vasodilatory effects of nicorandil on major coronary arteries were investigated in 22 patients undergoing cardiac catheterization. Nicorandil, 20 mg, was administered sublingually to 11 consecutive patients and 40 mg to 11 others. Systemic blood pressure decreased significantly without affecting the heart rate. A total of 103 selected coronary artery segments, including 17 stenotic segments, were analyzed quantitatively using a computer-assisted coronary angiographic analysis system. After administration of 20 or 40 mg of nicorandil, a significant increase of the mean diameter was observed in the proximal (+9% and +7%), midportion (+10% and +11%) and distal (+15% and +13%) parts of the left anterior descending coronary artery. Corresponding values for the proximal (+13% and +10%) and distal (+10% and +15%) segments of the circumflex artery were observed. An increase in the obstruction diameter was also observed in all but 3 of the analyzed stenotic segments. The results demonstrate that nicorandil, in the route and doses used, causes significant vasodilatation in the normal epicardial coronary segments as well as in most of the stenotic segments.

References

Jan 1, 1978·Japanese Heart Journal·Y UchidaS Murao
Dec 1, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·W R KukovetzG Pöch
Jul 1, 1985·Journal of Cardiovascular Pharmacology·K C PreussD C Warltier
Nov 1, 1985·Journal of Cardiovascular Pharmacology·G G BelzB Schneider
Sep 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·P D VerdouwP R Saxena
May 1, 1983·Journal of Cardiovascular Pharmacology·S Holzmann
May 1, 1984·Journal of Cardiovascular Pharmacology·K A LampingG J Gross
Jan 1, 1984·European Journal of Clinical Pharmacology·G G BelzG Wagner
Dec 1, 1980·European Heart Journal·P W SerruysP G Hugenholtz

❮ Previous
Next ❯

Citations

Jul 1, 1996·Journal of Clinical Pharmacology·M GoldschmidtW H Frishman
Feb 1, 1994·Cardiovascular Drugs and Therapy·I NakaeM Kinoshita
Feb 1, 1991·Cardiovascular Drugs and Therapy·K HashimotoY Ohbayashi
Apr 1, 1992·Pharmacology & Toxicology·K E Andersson
May 1, 1992·The American Journal of Cardiology·H SuryapranataP W Serruys

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.